DE1492157A1 - Mittel zum fruehzeitigen Graviditaetsnachweis bei Haustieren - Google Patents
Mittel zum fruehzeitigen Graviditaetsnachweis bei HaustierenInfo
- Publication number
- DE1492157A1 DE1492157A1 DE19621492157 DE1492157A DE1492157A1 DE 1492157 A1 DE1492157 A1 DE 1492157A1 DE 19621492157 DE19621492157 DE 19621492157 DE 1492157 A DE1492157 A DE 1492157A DE 1492157 A1 DE1492157 A1 DE 1492157A1
- Authority
- DE
- Germany
- Prior art keywords
- pregnancy
- estradiol
- means according
- sesame oil
- destosterone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001465754 Metazoa Species 0.000 title claims description 17
- 230000035935 pregnancy Effects 0.000 title description 26
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims description 9
- 239000008159 sesame oil Substances 0.000 claims description 8
- 235000011803 sesame oil Nutrition 0.000 claims description 8
- 241000282887 Suidae Species 0.000 claims description 7
- 241000283086 Equidae Species 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 5
- 241000283690 Bos taurus Species 0.000 claims description 4
- RSEPBGGWRJCQGY-RBRWEJTLSA-N Estradiol valerate Chemical compound C1CC2=CC(O)=CC=C2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCC)[C@@]1(C)CC2 RSEPBGGWRJCQGY-RBRWEJTLSA-N 0.000 claims description 4
- 229960002903 benzyl benzoate Drugs 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 229940094957 androgens and estrogen Drugs 0.000 claims description 3
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 claims description 2
- UYIFTLBWAOGQBI-BZDYCCQFSA-N Benzhormovarine Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4O)C)CC2=CC=3OC(=O)C1=CC=CC=C1 UYIFTLBWAOGQBI-BZDYCCQFSA-N 0.000 claims description 2
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- OKFBXYQPCPWWRP-SHDAAXGTSA-N [(8r,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] hexadecanoate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@@]1(C)CC2 OKFBXYQPCPWWRP-SHDAAXGTSA-N 0.000 claims description 2
- 239000008121 dextrose Substances 0.000 claims description 2
- 229950002007 estradiol benzoate Drugs 0.000 claims description 2
- 229960004766 estradiol valerate Drugs 0.000 claims description 2
- 229960002568 ethinylestradiol Drugs 0.000 claims description 2
- 229960003484 testosterone enanthate Drugs 0.000 claims description 2
- VOCBWIIFXDYGNZ-IXKNJLPQSA-N testosterone enanthate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC2 VOCBWIIFXDYGNZ-IXKNJLPQSA-N 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims 2
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 claims 2
- TXHUMRBWIWWBGW-UHFFFAOYSA-N Estradiol undecylate Natural products C1CC2=CC(O)=CC=C2C2C1C1CCC(OC(=O)CCCCCCCCCC)C1(C)CC2 TXHUMRBWIWWBGW-UHFFFAOYSA-N 0.000 claims 1
- TXHUMRBWIWWBGW-GVGNIZHQSA-N estradiol undecylate Chemical compound C1CC2=CC(O)=CC=C2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCCCCCCCC)[C@@]1(C)CC2 TXHUMRBWIWWBGW-GVGNIZHQSA-N 0.000 claims 1
- 229950005281 estradiol undecylate Drugs 0.000 claims 1
- 238000010255 intramuscular injection Methods 0.000 claims 1
- 239000007927 intramuscular injection Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 12
- 230000012173 estrus Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 8
- 229960003604 testosterone Drugs 0.000 description 6
- 229940011871 estrogen Drugs 0.000 description 5
- 239000000262 estrogen Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000003098 androgen Substances 0.000 description 3
- -1 steroid esters Chemical class 0.000 description 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- PDMMFKSKQVNJMI-BLQWBTBKSA-N Testosterone propionate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CC)[C@@]1(C)CC2 PDMMFKSKQVNJMI-BLQWBTBKSA-N 0.000 description 2
- 238000002306 biochemical method Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000016087 ovulation Effects 0.000 description 2
- 229960001712 testosterone propionate Drugs 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- GCKMFJBGXUYNAG-UHFFFAOYSA-N 17alpha-methyltestosterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C)(O)C1(C)CC2 GCKMFJBGXUYNAG-UHFFFAOYSA-N 0.000 description 1
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 1
- GCKMFJBGXUYNAG-HLXURNFRSA-N Methyltestosterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 GCKMFJBGXUYNAG-HLXURNFRSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 229940061641 androsterone Drugs 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 210000002451 diencephalon Anatomy 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229960001566 methyltestosterone Drugs 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000000624 ovulatory effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DESC032187 | 1962-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1492157A1 true DE1492157A1 (de) | 1969-09-18 |
Family
ID=7432349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19621492157 Pending DE1492157A1 (de) | 1962-10-05 | 1962-10-05 | Mittel zum fruehzeitigen Graviditaetsnachweis bei Haustieren |
Country Status (7)
| Country | Link |
|---|---|
| BE (1) | BE638306A (cs) |
| CH (1) | CH480842A (cs) |
| DE (1) | DE1492157A1 (cs) |
| DK (1) | DK106647C (cs) |
| GB (1) | GB1055274A (cs) |
| NL (1) | NL298736A (cs) |
| SE (1) | SE345598B (cs) |
-
0
- NL NL298736D patent/NL298736A/xx unknown
- BE BE638306D patent/BE638306A/xx unknown
-
1962
- 1962-10-05 DE DE19621492157 patent/DE1492157A1/de active Pending
-
1963
- 1963-10-04 CH CH1226163A patent/CH480842A/de not_active IP Right Cessation
- 1963-10-04 GB GB3923563A patent/GB1055274A/en not_active Expired
- 1963-10-04 SE SE1089163A patent/SE345598B/xx unknown
- 1963-10-05 DK DK469563A patent/DK106647C/da active
Also Published As
| Publication number | Publication date |
|---|---|
| SE345598B (cs) | 1972-06-05 |
| CH480842A (de) | 1969-11-15 |
| DK106647C (da) | 1967-02-27 |
| BE638306A (cs) | |
| NL298736A (cs) | |
| GB1055274A (en) | 1967-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69230040T2 (de) | Biokompatibles implantat für die zeitliche abstimmung der ovulation von stuten | |
| DE69010294T2 (de) | Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs. | |
| DE69721462T2 (de) | Verfahren zur Förderung von Ovulation und Geburt bei Säugetieren | |
| DE2818586A1 (de) | Neue zootechnische zusammensetzungen | |
| DE2149744A1 (de) | 19-Nor-sprioxenon als anabolisches Mittel | |
| DE1492157A1 (de) | Mittel zum fruehzeitigen Graviditaetsnachweis bei Haustieren | |
| Yamada | Über bedeutungsfremde Selbstdifferenzierung der präsumptiven Rückenmuskulatur des Molchkeimes bei Isolation. | |
| DE2649914A1 (de) | Mittel zum foerdern der fortpflanzungsfaehigkeit von haustieren | |
| DE2323615C2 (cs) | ||
| DE3533175A1 (de) | Antigestagene zur verschiebung der endometrialen reifung | |
| DE69423016T2 (de) | Verfahren zur Steigerung der Gewichtszunahme von Säugetieren | |
| Lloyd et al. | Efficacy of long acting oxytetracycline in the treatment and control of bovine dermatophilosis | |
| DE1617450A1 (de) | Verfahren zur Verbesserung der Konzeptionsrate von weiblichen Haussaeugetieren | |
| DE4334728A1 (de) | Neue Verwendung von Altrenogest | |
| DE1617538C3 (de) | Verfahren zur Herstellung von Tetanus-Antitoxin | |
| DE1940096A1 (de) | Verfahren zur Erhoehung der Traechtigkeitsrate und der Lebendgeburten bei Kuehen | |
| DE885649C (de) | Verfahren zur Herstellung eines Beifutters fuer Haustiere | |
| DE1692517C3 (de) | Injektionsmittel zum Masten von männlichen Schiachttieren in Form einer Pflanzenollosung | |
| Ribary | Nicotine in pregnancy: acute and persistent effects on central monoaminergic systems in rat fetus and offspring | |
| DE823842C (de) | Verfahren zur Herstellung von Viehfutter | |
| DE1692392C3 (de) | Beifuttermittel | |
| DE2449653A1 (de) | Tiermastmittel | |
| DE3610877A1 (de) | Verbessertes verfahren zur stimulierung der geschlechtstaetigkeit von voegeln und als nutztieren gehaltenen saeugetieren sowie zur herstellung von zu ihrer vermehrung geeigneten samenzellen | |
| DE1191623B (de) | Vorrichtung zur Einzelhaltung von abgesetzten Ferkeln | |
| Holtz et al. | Geburtsauslösung beim Schwein mit einem Prostaglandin F Analog (“Cloprostenol” ICI 80996) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SH | Request for examination between 03.10.1968 and 22.04.1971 |